A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines.

Saved in:
Bibliographic Details
Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines.
Authors: Yen, Yu-Hsiu1 (AUTHOR), Tsau, Tzu-Wen2 (AUTHOR), Lee, Chih-Hung3 (AUTHOR), Chen, Hsin-Han4 (AUTHOR), Lin, Chih-Hung5 (AUTHOR), Chen, Tim-Mo6 (AUTHOR), Pu, Chi-Ming1,7 (AUTHOR) pkman9335@msn.com
Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3717-3731. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01561-5